Claims including treating autism and children's teething not only got the Food and Drug Administration's attention for a Florida firm's cannabidiol-containing dietary supplements and topicals, they also piqued the Federal Trade Commission's interest.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?